585
Views
7
CrossRef citations to date
0
Altmetric
Review

Live attenuated influenza vaccine tetravalent: a clinical review

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fan Yang, Lei Ma, Jian Zhou, Yinjie Wu, Jingxia Gao, Shaohui Song, Xingliang Geng, Qi Guo, Zhuofan Li, Weidong Li, Guoyang Liao & Yufeng Li. (2017) Development and identification of a new Vero cell-based live attenuated influenza B vaccine by a modified classical reassortment method. Expert Review of Vaccines 16:8, pages 855-863.
Read now

Articles from other publishers (6)

Talal S Al-Qaisi & Berjas Abumsimir. (2023) Vaccination strategies, the power of the unmatched double hits. Future Science OA 9:9.
Crossref
Feixia Gao, Tianhan Yang, Xueying Liu, Feifei Xiong, Jian Luo, Yinglei Yi, Jiangfeng Fan, Ze Chen & Wen-Song Tan. (2020) MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection. Vaccines 8:1, pages 65.
Crossref
Yao Sun, Zhenwei Shen, Chun Zhang, Yanming Yi, Kunying Zhu, Fei Xu & Wei Kong. (2019) Development of a Stable Liquid Formulation for Live Attenuated Influenza Vaccine. Journal of Pharmaceutical Sciences 108:7, pages 2315-2322.
Crossref
Larisa Rudenko, Irina Kiseleva, Elena Krutikova, Ekaterina Stepanova, Andrey Rekstin, Svetlana Donina, Maria Pisareva, Elena Grigorieva, Kirill Kryshen, Arman Muzhikyan, Marina Makarova, Erin Grace Sparrow, Guido Torelli & Marie-Paule Kieny. (2018) Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. PLOS ONE 13:12, pages e0208028.
Crossref
Svetlana Shcherbik, Paul Carney, Nicholas Pearce, James Stevens, Vivien G. Dugan, David E. Wentworth & Tatiana Bousse. (2018) Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines. Virology 522, pages 65-72.
Crossref
Kyuri KangSeunghoon HanTaegon HongSangil JeonJeongki PaekJin Han KangDong-Seok Yim. (2016) Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial. Yonsei Medical Journal 57:6, pages 1354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.